Irish
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
hydrocarbon/seizures
Sábháiltear an nasc chuig an gearrthaisce
9 torthaí
Compositions and method for treating epilepsy and convulsions
Ní féidir ach le húsáideoirí cláraithe ailt a aistriú
Logáil Isteach / Cláraigh
BACKGROUND OF THE INVENTION
1. Field of the Invention
The invention concerns a method of using aminobenz amides as anticonvulsants, novel nitrobenzamides and amino benzamides prepared therefrom and compositions thereof which are useful anticonvulsants. More particularly, the invention concerns novel
Imidazodiazepine derivatives
Ní féidir ach le húsáideoirí cláraithe ailt a aistriú
Logáil Isteach / Cláraigh
SUMMARY OF THE INVENTION
The present invention is concerned with imidazodiazepine derivatives. In particular, it provides imidazodiazepine derivatives of the formula ##STR3## wherein A together with the two carbon atoms denoted by .alpha. and .beta. represents one of the following groups: ##STR4##
Imidazo[4,5-c]pyridin-4-one analogues as GABAA receptor ligands
Ní féidir ach le húsáideoirí cláraithe ailt a aistriú
Logáil Isteach / Cláraigh
CROSS REFERENCE TO RELATED APPLICATIONS
This application claims priority under 35 U.S.C. .sctn.119 from GB Application No. 0225399.5 filed Oct. 31, 2002.
The present invention relates to a class of substituted imidazo-pyridinone derivatives and to their use in therapy. More particularly, this
3-Phenyl-imidazo-pyrimidine derivatives as ligands for GABA receptors
Ní féidir ach le húsáideoirí cláraithe ailt a aistriú
Logáil Isteach / Cláraigh
CROSS REFERENCE TO RELATED APPLICATIONS
This application is a U.S. National Phase application under 35 U.S.C. .sctn.371 of PCT Application No. PCT/GB01/02158, filed May 17, 2001, which claims priority under 35 U.S.C. .sctn.119 from GB Application No. 0012709.2, filed May 24, 2000 and GB Application
Substituted pyrido-pyridazine derivatives which enhance cognition via the GABA-.sub.A receptors
Ní féidir ach le húsáideoirí cláraithe ailt a aistriú
Logáil Isteach / Cláraigh
CROSS REFERENCE TO RELATED APPLICATIONS
This application is a U.S. National Phase application under 35 U.S.C. .sctn. 371 of PCT Application No. PCT/GB2003/004677, filed Oct. 29, 2003, which claims priority under 35 U.S.C. .sctn. 119 from GB Application No. 0225501.6, filed Nov. 1, 2002.
The present
High temperature heat-resistant oil-based release agent, high temperature heat-resistant electrostatic application-type oil-based release agent, and application method therefor
Ní féidir ach le húsáideoirí cláraithe ailt a aistriú
Logáil Isteach / Cláraigh
TECHNICAL FIELD
The present invention relates to an oil-based release agent (also referred to as lubricant) used for casting or die casting of aluminum, magnesium, zinc, or a non-ferrous metal such as an alloy containing these elements, and a method for applying the oil-based release
Spiro compounds
Ní féidir ach le húsáideoirí cláraithe ailt a aistriú
Logáil Isteach / Cláraigh
This application is a U.S. national stage of International Application No. PCT/JP02/07922 filed Aug. 2, 2002.
TECHNICAL FIELD
The present invention is useful in medical fields. In more detail, spiro compounds of the present invention have an effect as neuropeptide Y receptor antagonists and are
Imidazo[1,2-b]pyridazine analogues as anxiolytics and cognition enhancers
Ní féidir ach le húsáideoirí cláraithe ailt a aistriú
Logáil Isteach / Cláraigh
CROSS REFERENCE TO RELATED APPLICATIONS
This application claims priority under 35 U.S.C. .sctn. 119 from GB Application No. 0223349.2 filed Oct. 8, 2002.
The present invention relates to a class of substituted imidazo-pyridazine derivatives and to their use in therapy. More particularly, this
Imidazopyrazinones as GABA-A receptor anxiolytics
Ní féidir ach le húsáideoirí cláraithe ailt a aistriú
Logáil Isteach / Cláraigh
CROSS REFERENCE TO RELATED APPLICATIONS
This application is a U.S. National Phase application under 35 U.S.C. .sctn. 371 of PCT Application No. PCT/GB2003/004685, filed Oct. 29, 2003, which claims priority under 35 U.S.C. .sctn. 119 from GB Application No. 0225923.2, filed Nov. 6, 2002, GB
An bunachar luibheanna míochaine is iomláine le tacaíocht ón eolaíocht
- Oibreacha i 55 teanga
- Leigheasanna luibhe le tacaíocht ón eolaíocht
- Aitheantas luibheanna de réir íomhá
- Léarscáil GPS idirghníomhach - clibeáil luibheanna ar an láthair (ag teacht go luath)
- Léigh foilseacháin eolaíochta a bhaineann le do chuardach
- Cuardaigh luibheanna míochaine de réir a n-éifeachtaí
- Eagraigh do chuid spéiseanna agus fanacht suas chun dáta leis an taighde nuachta, trialacha cliniciúla agus paitinní
Clóscríobh symptom nó galar agus léigh faoi luibheanna a d’fhéadfadh cabhrú, luibh a chlóscríobh agus galair agus comharthaí a úsáidtear ina choinne a fheiceáil.
* Tá an fhaisnéis uile bunaithe ar thaighde eolaíoch foilsithe
